Metabolic Aspects of Polycystic Ovary Syndrome

    August 2015 in “ Postgraduate obstetrics & gynecology ”
    Amy S. Dhesi, Sara S. Morelli
    Studysummary This article discusses the unapproved use of metformin for treating polycystic ovary syndrome; it provides educational content for physicians but reports no new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on journals.lww.com →
    Discuss this study in the Community →

    Research cited in this study 5

    1. Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline The Journal of Clinical Endocrinology and Metabolism · 2013
    2. Treatment of Obstructive Sleep Apnea Improves Cardiometabolic Function in Young Obese Women with Polycystic Ovary Syndrome The Journal of Clinical Endocrinology & Metabolism · 2011
    3. Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome Society The Journal of Clinical Endocrinology & Metabolism · 2010
    4. ACOG Practice Bulletin No. 108: Polycystic Ovary Syndrome Obstetrics & Gynecology · 2009
    5. Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome Fertility and Sterility · 2004